About Us

Founded in 2011, MKM Ventures an investment, management and development company for early-stage electronic medical devices. We are located in the BioInc on the campus of New York Medical College and funded by the Pritzker-Vlock family office. We work with entrepreneurs, universities, inventors and corporate partners to seed and develop breakthrough technologies that improve patient’s health. 


Marc Zemel, CEO


Serial medical device entrepreneur. Previously raised $15M and led hospital cardiac output monitor (Retia Medical) to FDA clearance and market launch. 18 patents. MBA Yale, MS Mech. Eng. MIT.

Jerry Korten, Executive VP


Expertise in algorithm development and embedded engineering of patient monitoring and mobile health devices. Previously CEO of Versamed, which he sold to GE Healthcare. MS University of Michigan.

Jeff Reynolds, PhD, VP of R&D


Expertise in consumer medical device hardware development. Most recently Director R&D and Hardware Engineering for Bayer (~20 years) connected glucose monitors. 60 patents issued worldwide. PhD Electrical Eng. Purdue.